We are live on ! Find out more
OA

Oracle Alpha Portfolio holdings

AUM $55.7M
This Fund
S&P 500
This Quarter Est. Return
+18.84%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$77.3M
AUM Growth
Cap. Flow
+$69.1M
Cap. Flow %
89.47%
Top 10 Hldgs %
11.25%
Holding
247
New
247
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$911K
2
LLY icon
Eli Lilly
LLY
+$911K
3
INTC icon
Intel
INTC
+$846K
4
TMO icon
Thermo Fisher Scientific
TMO
+$781K
5
GTLB icon
GitLab
GTLB
+$779K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 24.1%
2 Healthcare 17.27%
3 Consumer Discretionary 12.72%
4 Financials 10.67%
5 Energy 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHEN icon
176
Shenandoah Telecom
SHEN
$664M
$215K 0.28%
+9,926
New +$222K
WKC icon
177
World Kinect Corp
WKC
$2.04B
$213K 0.28%
+9,346
New +$196K
NKE icon
178
Nike
NKE
$61.9B
$212K 0.27%
+1,956
New +$210K
HSY icon
179
Hershey
HSY
$35.2B
$212K 0.27%
+1,135
New +$215K
ARMK icon
180
Aramark
ARMK
$15B
$211K 0.27%
+7,522
New +$204K
NEE icon
181
NextEra Energy
NEE
$181B
$211K 0.27%
+3,479
New +$198K
HCA icon
182
HCA Healthcare
HCA
$87.2B
$210K 0.27%
+777
New +$192K
ASAN icon
183
Asana
ASAN
$1.92B
$209K 0.27%
+11,012
New +$214K
RLAY icon
184
Relay Therapeutics
RLAY
$4.1B
$206K 0.27%
+18,716
New +$158K
NUE icon
185
Nucor
NUE
$58.6B
$205K 0.27%
+1,177
New +$187K
UNH icon
186
UnitedHealth
UNH
$376B
$205K 0.27%
+389
New +$207K
ACLX
187
DELISTED
Arcellx
ACLX
$204K 0.26%
+3,674
New +$166K
AHCO icon
188
AdaptHealth
AHCO
$1.47B
$204K 0.26%
+27,922
New +$220K
CELH icon
189
Celsius Holdings
CELH
$7.47B
$203K 0.26%
+3,728
New +$199K
OGN icon
190
Organon & Co
OGN
$3.56B
$199K 0.26%
+13,833
New +$188K
MFIN icon
191
Medallion Financial
MFIN
$229M
$199K 0.26%
+20,199
New +$168K
FLWS icon
192
1-800-Flowers.com
FLWS
$250M
$196K 0.25%
+18,210
New +$156K
VIR icon
193
Vir Biotechnology
VIR
$1.46B
$192K 0.25%
+19,062
New +$174K
CWK icon
194
Cushman & Wakefield Ltd
CWK
$3.14B
$191K 0.25%
+17,650
New +$147K
NVCR icon
195
NovoCure
NVCR
$1.73B
$191K 0.25%
+12,767
New +$171K
TRDA icon
196
Entrada Therapeutics
TRDA
$264M
$189K 0.24%
+12,500
New +$185K
NECB icon
197
Northeast Community Bancorp
NECB
$368M
$188K 0.24%
+10,623
New +$172K
ROIV icon
198
Roivant Sciences
ROIV
$24.5B
$186K 0.24%
+16,601
New +$162K
AMPL icon
199
Amplitude
AMPL
$1.18B
$181K 0.23%
+14,200
New +$158K
NRIX icon
200
Nurix Therapeutics
NRIX
$2.41B
$180K 0.23%
+17,434
New +$119K

Similar funds

Oracle Alpha's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for Oracle Alpha, which disclosed 247 positions worth $77.3M. Its ten largest holdings account for 11% of the portfolio.

Its largest position is NVIDIA: 19,660 shares worth $974K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, followed by Healthcare and Consumer Discretionary.

  • Oracle Alpha's largest Q4 2023 buy was NVIDIA: 19,660 shares worth $974K.
  • Oracle Alpha's ten largest holdings make up 11% of its $77.3M portfolio in Q4 2023.
  • Oracle Alpha disclosed 247 positions in Q4 2023, its first 13F filing on record.

Based on Oracle Alpha's 13F filing for Q4 2023, filed 14 Feb 2024.